Stephen Kent to Nanoparticles
This is a "connection" page, showing publications Stephen Kent has written about Nanoparticles.
Connection Strength
4.308
-
Patient-Specific Nanoparticle Targeting in Human Leukemia Blood. ACS Nano. 2024 10 22; 18(42):29021-29035.
Score: 0.716
-
Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans. ACS Nano. 2024 10 01; 18(39):27077-27089.
Score: 0.713
-
Person-Specific Biomolecular Coronas Modulate Nanoparticle Interactions with Immune Cells in Human Blood. ACS Nano. 2020 11 24; 14(11):15723-15737.
Score: 0.545
-
Beyond PEG: Emerging Polymer Lipid Alternatives for Lipid Nanoparticle (LNP) Formulations. Adv Sci (Weinh). 2026 Sep; 13(50):e77145.
Score: 0.203
-
PEG-free Lipid Nanoparticles for mRNA Delivery: Superhydrophilic Sulfoxide Polymer Coatings. Biomacromolecules. 2026 Jan 12; 27(1):624-639.
Score: 0.194
-
Influence of hydrophilic polymers on the accelerated blood clearance of mRNA lipid nanoparticles upon repeated administration. Nanoscale Horiz. 2025 Nov 17; 10(12):3396-3404.
Score: 0.193
-
Mucosal vaccination against SARS-CoV-2 using recombinant influenza viruses delivering self-assembling nanoparticles. Vaccine. 2025 02 06; 46:126668.
Score: 0.182
-
Replacing poly(ethylene glycol) with RAFT lipopolymers in mRNA lipid nanoparticle systems for effective gene delivery. Int J Pharm. 2024 Nov 15; 665:124695.
Score: 0.178
-
Engineered Ferritin Nanoparticle Vaccines Enable Rapid Screening of Antibody Functionalization to Boost Immune Responses. Adv Healthc Mater. 2023 07; 12(17):e2202595.
Score: 0.160
-
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine. ACS Nano. 2022 08 23; 16(8):11769-11780.
Score: 0.153
-
From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases. Acta Biomater. 2021 09 01; 131:16-40.
Score: 0.142
-
Controlling the Biological Fate of Micellar Nanoparticles: Balancing Stealth and Targeting. ACS Nano. 2020 10 27; 14(10):13739-13753.
Score: 0.135
-
Cellular Interactions of Liposomes and PISA Nanoparticles during Human Blood Flow in a Microvascular Network. Small. 2020 08; 16(33):e2002861.
Score: 0.133
-
Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory B cell maturation. JCI Insight. 2020 05 21; 5(10).
Score: 0.132
-
Characterization of Key Bio-Nano Interactions between Organosilica Nanoparticles and Candida albicans. ACS Appl Mater Interfaces. 2019 Sep 25; 11(38):34676-34687.
Score: 0.126
-
Templated Polymer Replica Nanoparticles to Facilitate Assessment of Material-Dependent Pharmacokinetics and Biodistribution. ACS Appl Mater Interfaces. 2017 Oct 04; 9(39):33683-33694.
Score: 0.110
-
Thiol-Reactive Star Polymers Display Enhanced Association with Distinct Human Blood Components. ACS Appl Mater Interfaces. 2017 Apr 12; 9(14):12182-12194.
Score: 0.106
-
Human immune cell targeting of protein nanoparticles--caveospheres. Nanoscale. 2016 Apr 21; 8(15):8255-65.
Score: 0.100
-
Anti-PEG antibodies in nanomedicine: Mechanisms, risks, and opportunities. Adv Drug Deliv Rev. 2026 Sep; 236:115925.
Score: 0.050
-
Current and future nanoparticle vaccines for COVID-19. EBioMedicine. 2021 Dec; 74:103699.
Score: 0.037